Dr. John Cush RheumNow
5 years 10 months ago
Check out our latest.
PIANO Study - Safety of Biologics in Pregnancy
https://t.co/XskLByJZ9n https://t.co/JBHKo0T0jX
Dr. John Cush RheumNow
5 years 10 months ago
New podcast!
Dr Jack Cush takes questions from RheumNow listeners
PIANO Study - Safety of Biologics in Pregnancy
Premature osteoporosis and high tryptase
Mega-methotrexate doses
SLE criteria and SLEDAI substitutions
https://t.co/45n3KjJHqs
Dr. John Cush RheumNow
5 years 10 months ago
#BestACR20Tweets
RT @uptoTate : Study out of China, #ABS1892 shows that patient reported outcomes using self assessments are important in AS T2T and decreasing flare rates #ACR20 @RheumNow. https://t.co/vWjvAEeDMi https://t.co/HdMKSkkJ8I
Dr. John Cush RheumNow
5 years 10 months ago
#BestACR20Tweets
RT @RichardPAConway : Dr Kaellmark reports on immunogenicity of adjuvant herpes zoster subunit vaccine in RA patients treated with JAKi. 40 RA patients and 20 controls. Satisfactory serological responses and tolerability seen. @rheumnow #ACR20 Abstr#1997 https://t.co/TR9IS9hUgu
Dr. John Cush RheumNow
5 years 10 months ago
Missing the Mark: AxSpa Treat to Target (TICOSPA Trial): Dr. Lianne Gensler #ACR20
https://t.co/ePrhQ90kwD
Dr. John Cush RheumNow
5 years 10 months ago
Check out our latest article from Richard Conway ( @RichardPAConway) #ACR20
The tantalising prospect of glucocorticoid-free treatments for systemic vasculitis
https://t.co/VG1ah3Nq5c https://t.co/js3l527VHg
Dr. John Cush RheumNow
5 years 10 months ago
Revisit #ACR20 through the RheumNow podcast. Day 2, Part III available now.
https://t.co/rgvlZzVMkX
Dr. John Cush RheumNow
5 years 10 months ago
#BestACR20Tweets
RT @MeralElRamahiMD : A large observat study showed no difference in risk of major CV events in RA pts that were newly started on either MTX or HCQ. A greater stroke risk but lower risk of MI; hospitalized HF was seen in MTX initiators. #Abst1993 #ACR20
Dr. John Cush RheumNow
5 years 10 months ago
Check out the latest from Dr. Bella Mehta ( @bella_mehta) #ACR20
Racial disparities in Bilateral Knee Arthroplasty in Osteoarthritis
https://t.co/yataL7H8X4 https://t.co/xT1vCBDLyZ
Dr. John Cush RheumNow
5 years 10 months ago
Revisit #ACR20 through the RheumNow podcast. Day 2, Part II available now.
https://t.co/NipWyiTqtl https://t.co/kBz2jVaSLN
Dr. John Cush RheumNow
5 years 10 months ago
#BestACR20Tweets
"RT @drdavidliew : Just a reminder:
inflammatory arthritis irAEs can occur at almost any time after immune checkpoint inhibitor cancer immunotherapy is commenced.
@LoyolaChicago #ACR20 ABST1566 @RheumNow https://t.co/x7DLzZcn9o https://t.co/OmpTAorA13
Dr. John Cush RheumNow
5 years 10 months ago
Dr. Ruderman ( @JointMD) discusses a new pathway - the use of deucravacitinib - to treat psoriatic arthritis at #ACR20.
https://t.co/1uz47jKVPv https://t.co/1I5B14w9Ox
Dr. John Cush RheumNow
5 years 10 months ago
Imaging and Large Vessel Vasculitis: Dr. Alexa S. Meara interviews Dr. Kaitlin Quinn #ACR20
https://t.co/CWN2C1P6Fz https://t.co/yHg63VPkiW
Dr Jack Cush takes questions from RheumNow listeners
PIANO Study - Safety of Biologics in Pregnancy
Premature osteoporosis and high tryptase
Mega-methotrexate doses
SLE criteria and SLEDAI substitutions

